You just read:

MabVax Therapeutics Expands Patient Enrollment in Phase I Trial for Treatment of Pancreatic Cancer to Memorial Sloan Kettering Cancer Center

News provided by

MabVax Therapeutics Holdings, Inc.

07 Jun, 2016, 08:00 ET